Evidence map›Paper›PMID 39212415›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2024

IFN Receptor 2 Regulates TNF-α-Mediated Damaging Inflammation during Aspergillus Pulmonary Infection.

Agnieszka Rynda-Apple, Jazmin Reyes Servin, Julianna Lenz, Julia Roemer, Evelyn E Benson, Monica N Hall, Kelly M Shepardson

Abstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Agnieszka Rynda-AppleDepartment of Microbiology and Cell Biology, Montana State University, Bozeman, MT.
Jazmin Reyes ServinDepartment of Molecular and Cell Biology, University of California, Merced, Merced, CA.ORCID 0009-0003-7738-3580
Julianna LenzDepartment of Molecular and Cell Biology, University of California, Merced, Merced, CA.ORCID 0009-0009-7587-702X
Julia RoemerDepartment of Microbiology and Cell Biology, Montana State University, Bozeman, MT.ORCID 0000-0001-9675-7945
Evelyn E BensonDepartment of Microbiology and Cell Biology, Montana State University, Bozeman, MT.
Monica N HallDepartment of Microbiology and Cell Biology, Montana State University, Bozeman, MT.ORCID 0000-0002-4009-4617
Kelly M ShepardsonDepartment of Microbiology and Cell Biology, Montana State University, Bozeman, MT.ORCID 0000-0003-3631-2594

Funding

Research Core (Developmental Research Project Program)P20GM103474 · NIGMS · MONTANA STATE UNIVERSITY - BOZEMAN · PI Ann Therese Bertagnolli · 2012 to 2026
$60.0M
The role of IFNAR2 in regulation of damage during A. fumigatus lung infectionK22AI153671 · NIAID · UNIVERSITY OF CALIFORNIA, MERCED · PI SHEPARDSON, KELLY · 2022 to 2023
$268k
American Association of Immunologists Careers in Immunology FellowshipFrancis Family Foundation (FF)HHS | NIH | NIAID | Division of Microbiology and Infectious Diseases (DMID) K22AI153671HHS | NIH | NIAID | Division of Microbiology and Infectious Diseases (DMID) R01AI04905HHS | NIH | NIGMS | MTINBRE P20GM103474M.J. Murdock Charitable Trust (MJMCT)MSU Agriculture Experiment StationNIAID NIH HHS K22 AI153671NIGMS NIH HHS P20 GM103474
6 · The paper itself

Abstract

The increased incidence of invasive pulmonary aspergillosis, caused by Aspergillus fumigatus, occurring in patients infected with severe influenza or SARS-CoV-2, suggests that antiviral immune responses create an environment permissive to fungal infection. Our recent evidence suggests that absence of the type I IFN receptor 2 subunit (IFNAR2) of the heterodimeric IFNAR1/2 receptor is allowing for this permissive immune environment of the lung through regulation of damage responses. Because damage is associated with poor outcome to invasive pulmonary aspergillosis, this suggested that IFNAR2 may be involved in A. fumigatus susceptibility. In this study, we determined that absence of IFNAR2 resulted in increased inflammation, morbidity, and damage in the lungs in response to A. fumigatus challenge, whereas absence of IFNAR1 did not. Although the Ifnar2-/- mice had increased morbidity, we found that the Ifnar2-/- mice cleared more conidia compared with both wild-type and Ifnar1-/- mice. However, this early clearance did not prevent invasive disease from developing in the Ifnar2-/- mice as infection progressed. Importantly, by altering the inflamed environment of the Ifnar2-/- mice early during A. fumigatus infection, by neutralizing TNF-α, we were able to reduce the morbidity and fungal clearance in these mice back to wild-type levels. Together, our results establish a distinct role for IFNAR2 in regulating host damage responses to A. fumigatus and contributing to an A. fumigatus-permissive environment through regulation of inflammation. Specifically, our data reveal a role for IFNAR2 in regulating TNF-α-mediated damage and morbidity during A. fumigatus infection.

Indexed as

Aspergillus fumigatusMice, Inbred C57BLMice, KnockoutReceptor, Interferon alpha-betaTumor Necrosis Factor-alphaAnimalsHumansInflammationLungMiceIfnar1 protein, mouseIfnar2 protein, mouseReceptor, Interferon alpha-betaTumor Necrosis Factor-alpha

Identifiers

PMID39212415
PMCPMC11816899

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.